The individually deferred dosing of G-CSF after autologous stem cell transplantation in patients with malignant lymphoma - results of multicentre randomised trial

被引：0
|
作者：
Faber, E
Pytlik, R
Trneny, M
Slaby, J
Kozak, T
Raida, L
Papalik, T
Zikesova, E
Zapletalova, J
Maresova, I
Hamouzova, M
Indrak, K
机构：
[1] Univ Hosp Olomouc, Olomouc, Czech Republic
[2] Univ Hosp Prague, Prague, Czech Republic
[3] Univ Hosp Vinohrady, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [1] Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma -: results of a prospective multicentre controlled trial
    Faber, Edgar
    Pytlik, Robert
    Slaby, Jiri
    Zapletalova, Jana
    Kozak, Tomas
    Raida, Ludek
    Papajik, Tomas
    Zikesova, Eva
    Maresova, Ivana
    Hamouzova, Marie
    Indrak, Karel
    Trneny, Marek
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (06) : 493 - 500
  • [2] G-CSF after autologous hemopoietic stem cell transplantation in malignant lymphoma
    Deliliers, GL
    Tagliaferri, E
    Annaloro, C
    Della Volpe, A
    Soligo, D
    Pozzoli, E
    Marconi, M
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1998, 56 (01): : 33 - 42
  • [3] A "single" dose of G-CSF after autologous stem cell transplantation in patients with malignant lymphoma - second interim analysis of multicentre randomised trial comparing standard schedule with delayed application and placebo
    Faber, E
    Pytlik, R
    Trneny, M
    Slaby, J
    Kozak, T
    Raida, L
    Papajik, T
    Zikesova, E
    Zapletalova, J
    Maresova, I
    Trnkova, M
    Indrak, K
    BONE MARROW TRANSPLANTATION, 2004, 33 : S122 - S122
  • [4] Pegylated G-CSF after autologous hematopoietic stem cell transplantation
    Annaloro, C.
    Usardi, P.
    Della Volpe, A.
    Onida, F.
    Basilico, C.
    Deliliers, G. Lambertenghi
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 74 - 74
  • [5] A "single" dose of G-CSF after autologous stem cell transplantation in patients with malignant lymphoma - Third interim analysis of multicentre randomized trial comparing standard schedule with delayed application and placebo.
    Faber, E
    Pytlik, R
    Trneny, M
    Slaby, J
    Kozak, T
    Raida, L
    Papajik, T
    Zikesova, E
    Zapletalova, J
    Maresova, I
    Hamouzova, M
    Indrak, K
    BLOOD, 2004, 104 (11) : 799A - 800A
  • [6] Comparision of benefits of early, delayed, and no administration of G-CSF after autologous peripheral blood stem cell transplantation in lymphoma patients
    Wylezol, Iwona
    Snarski, Emilian
    Markiewicz, Miroslaw
    Kyrcz-Krzemien, Slawomira
    Jedrzejczak, Wieslaw-Wiktor
    Walewski, Jan
    ANNALS OF TRANSPLANTATION, 2013, 18 : 336 - 341
  • [7] Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma
    P Mollee
    D Pereira
    T Nagy
    K Song
    R Saragosa
    A Keating
    M Crump
    Bone Marrow Transplantation, 2002, 30 : 273 - 278
  • [8] Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial
    Bolwell, BJ
    Pohlman, B
    Andresen, S
    Kalaycio, M
    Goormastic, M
    Wise, K
    Wakeling, A
    Dannley, R
    Overmoyer, B
    BONE MARROW TRANSPLANTATION, 1998, 21 (04) : 369 - 373
  • [9] Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial
    BJ Bolwell
    B Pohlman
    S Andresen
    M Kalaycio
    M Goormastic
    K Wise
    A Wakeling
    R Dannley
    B Overmoyer
    Bone Marrow Transplantation, 1998, 21 : 369 - 373
  • [10] Early or delayed administration of G-CSF after peripheral blood stem cell transplantation in lymphoma patients
    Wylezol, I.
    Snarski, E.
    Borawska, A.
    Halaburda, K.
    Jedrzejczak, W.
    Walewski, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S184 - S184
12345